Dr. Huma Sohail, MD
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Years since graduation
- 26
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 385
Licensed in Texas since 2011, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
GA license 73398 · TX license N8991 (first issued 2011; canc non-renewal)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Northeast Georgia Medical Center, Inc Gainesville, GA
Medical groups
- Southeastern Rheumatology Alliance (27 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 385
- Services billed
- 65,400
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Injection, golimumab, 1 mg, for intravenous use | 10,000 | 23 |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 10,000 | 14 |
| Injection, tocilizumab, 1 mg | 7,050 | 13 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,652 | 39 |
| Injection, rituximab, 10 mg | 2,142 | 19 |
| Established patient office or other outpatient visit, 30-39 minutes | 453 | 213 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 424 | 218 |
| Blood test, comprehensive group of blood chemicals | 424 | 217 |
| Measurement c-reactive protein for detection of infection or inflammation | 396 | 211 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 395 | 211 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydroxychloroquine Sulfate Other prescribers in Gainesville, GA | 675 |
| Prednisone Other prescribers in Gainesville, GA | 529 |
| Methotrexate (methotrexate sodium) Other prescribers in Gainesville, GA | 412 |
| Pregabalin Other prescribers in Gainesville, GA | 316 |
| Gabapentin Other prescribers in Gainesville, GA | 298 |
| Sulfasalazine Other prescribers in Gainesville, GA | 256 |
| Duloxetine Hcl Other prescribers in Gainesville, GA | 250 |
| Leflunomide Other prescribers in Gainesville, GA | 238 |
| Tramadol Hcl Other prescribers in Gainesville, GA | 159 |
| Humira(Cf) Pen (adalimumab) Other prescribers in Gainesville, GA | 106 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 112 payments worth $2,417 in total to this clinician.
| AbbVie Inc. | $714 |
|---|---|
| Novartis Pharmaceuticals Corporation | $416 |
| Janssen Biotech, Inc. | $274 |
| Amgen Inc. | $243 |
| Genzyme Corporation | $166 |
| UCB, Inc. | $142 |
| Pfizer Inc. | $125 |
| E.r. Squibb & Sons, L.l.c. | $79.87 |
| Food and Beverage | $2,417 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.